New, highly selective inhibitor of FGFR2 driver alterations and resistance mutations Presented ByProf. Antoine Hollebecque, Institut Gustave Roussy, France TrialPhase 1/2, REFOCUS ConferenceESMO 2022 16 November, 2022 17:35